|
1
|
Santoro N: Perimenopause: From research to
practice. J Womens Health (Larchmt). 25:332–339. 2016. View Article : Google Scholar
|
|
2
|
Cunningham AC, Pal L, Wickham AP, Prentice
C, Goddard FGB, Klepchukova A and Zhaunova L: Chronicling menstrual
cycle patterns across the reproductive lifespan with real-world
data. Sci Rep. 14:101722024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Woods NF, Smith-Dijulio K, Percival DB,
Tao EY, Taylor HJ and Mitchell ES: Symptoms during the menopausal
transition and early postmenopause and their relation to endocrine
levels over time: Observations from the seattle midlife women's
health study. J Womens Health (Larchmt). 16:667–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng MH, Hsu CY, Wang SJ, Lee SJ, Wang PH
and Fuh JL: The relationship of self-reported sleep disturbance,
mood, and menopause in a community study. Menopause. 15:958–962.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang ST, Gu HY, Huang ZC, Li C, Liu WN and
Li R: Comparative accuracy of osteoporosis risk assessment tools in
postmenopausal women: A systematic review and network
meta-analysis. Int J Nurs Stud. 165:1050292025. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Freitas JPC, Santos JNV, de Moraes DB,
Gonçalves GT, Teixeira LADC, Otoni Figueiró MT, Cunha T, da Silva
Lage VK, Danielewicz AL, Figueiredo PHS, et al: Handgrip strength
and menopause are associated with cardiovascular risk in women with
obesity: A cross-sectional study. BMC Womens Health. 25:1572025.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Woods NF and Mitchell ES: Symptoms during
the perimenopause: Prevalence, severity, trajectory, and
significance in women's lives. Am J Med. 118(Suppl 12B): S14–S24.
2005. View Article : Google Scholar
|
|
8
|
Marsh WK, Templeton A, Ketter TA and
Rasgon NL: Increased frequency of depressive episodes during the
menopausal transition in women with bipolar disorder: Preliminary
report. J Psychiatr Res. 42:247–251. 2008. View Article : Google Scholar
|
|
9
|
Marsh WK, Ketter TA and Rasgon NL:
Increased depressive symptoms in menopausal age women with bipolar
disorder: Age and gender comparison. J Psychiatr Res. 43:798–802.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Truong D and Marsh W: Bipolar disorder in
the menopausal transition. Curr Psychiatry Rep. 21:1302019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Toffol E, Heikinheimo O and Partonen T:
Hormone therapy and mood in perimenopausal and postmenopausal
women: A narrative review. Menopause. 22:564–578. 2015. View Article : Google Scholar
|
|
12
|
Graziottin A and Serafini A: Depression
and the menopause: Why antidepressants are not enough? Menopause
Int. 15:76–81. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen H, Lu M, Lyu Q, Shi L, Zhou C, Li M,
Feng S, Liang X, Zhou X and Ren L: Mitochondrial dynamics
dysfunction: Unraveling the hidden link to depression. Biomed
Pharmacother. 175:1166562024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khan M, Baussan Y and Hebert-Chatelain E:
Connecting dots between mitochondrial dysfunction and depression.
Biomolecules. 13:6952023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rezin GT, Amboni G, Zugno AI, Quevedo J
and Streck EL: Mitochondrial dysfunction and psychiatric disorders.
Neurochem Res. 34:1021–1029. 2009. View Article : Google Scholar
|
|
16
|
Iwata K: Mitochondrial involvement in
mental disorders; energy metabolism, genetic, and environmental
factors. Methods Mol Biol. 1916:41–48. 2019. View Article : Google Scholar
|
|
17
|
Jou SH, Chiu NY and Liu CS: Mitochondrial
dysfunction and psychiatric disorders. Chang Gung Med J.
32:370–379. 2009.PubMed/NCBI
|
|
18
|
Beikoghli Kalkhoran S and Kararigas G:
Oestrogenic regulation of mitochondrial dynamics. Int J Mol Sci.
23:11182022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
No authors listed. Research on the
menopause in the 1990s. Report of a WHO scientific group. World
Health Organ Tech Rep Ser. 866:1–107. 1996.PubMed/NCBI
|
|
20
|
Schmidt PJ, Roca CA, Bloch M and Rubinow
DR: The perimenopause and affective disorders. Semin Reprod
Endocrinol. 15:91–100. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
No authors listed. Clinical challenges of
perimenopause: Consensus opinion of the North American menopause
society. Menopause. 7:5–13. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gordon JL, Girdler SS, Meltzer-Brody SE,
Stika CS, Thurston RC, Clark CT, Prairie BA, Moses-Kolko E, Joffe H
and Wisner KL: Ovarian hormone fluctuation, neurosteroids, and HPA
axis dysregulation in perimenopausal depression: A novel heuristic
model. Am J Psychiatry. 172:227–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Santoro N, Epperson CN and Mathews SB:
Menopausal symptoms and their management. Endocrinol Metab Clin
North Am. 44:497–515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng MH, Lee SJ, Wang SJ, Wang PH and Fuh
JL: Does menopausal transition affect the quality of life? A
longitudinal study of middle-aged women in Kinmen. Menopause.
14:885–890. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jia Y, Zhou Z, Xiang F, Hu W and Cao X:
Global prevalence of depression in menopausal women: A systematic
review and meta-analysis. J Affect Disord. 358:474–482. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Badawy Y, Spector A, Li Z and Desai R: The
risk of depression in the menopausal stages: A systematic review
and meta-analysis. J Affect Disord. 357:126–133. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oppermann K, Fuchs SC, Donato G, Bastos CA
and Spritzer PM: Physical, psychological, and menopause-related
symptoms and minor psychiatric disorders in a community-based
sample of Brazilian premenopausal, perimenopausal, and
postmenopausal women. Menopause. 19:355–360. 2012. View Article : Google Scholar
|
|
28
|
Li RX, Ma M, Xiao XR, Xu Y, Chen XY and Li
B: Perimenopausal syndrome and mood disorders in perimenopause:
Prevalence, severity, relationships, and risk factors. Medicine
(Baltimore). 95:e44662016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Soares CN and Taylor V: Effects and
management of the menopausal transition in women with depression
and bipolar disorder. J Clin Psychiatry. 68(Suppl 9): S16–S21.
2007.
|
|
30
|
Timur S and Sahin NH: The prevalence of
depression symptoms and influencing factors among perimenopausal
and postmenopausal women. Menopause. 17:545–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Freeman EW: Associations of depression
with the transition to menopause. Menopause. 17:823–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ye B, Zhou Y, Chen M, Chen C, Tan J and Xu
X: The association between depression during perimenopause and
progression of chronic conditions and multimorbidity: Results from
a Chinese prospective cohort. Arch Womens Ment Health. 26:697–705.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Marsh WK, Ketter TA, Crawford SL, Johnson
JV, Kroll-Desrosiers AR and Rothschild AJ: Progression of female
reproductive stages associated with bipolar illness exacerbation.
Bipolar Disord. 14:515–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bromberger JT, Matthews KA, Schott LL,
Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers
M and Randolph JF Jr: Depressive symptoms during the menopausal
transition: The Study of women's health across the nation (SWAN). J
Affect Disord. 103:267–272. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Krajewska-Ferishah K, Kułak-Bejda A,
Szyszko-Perłowska A, Shpakou A, Van Damme-Ostapowicz K and
Chatzopulu A: Risk of depression during menopause in women from
Poland, Belarus, Belgium, and Greece. J Clin Med. 11:33712022.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kulkarni J, Gavrilidis E, Hudaib AR,
Bleeker C, Worsley R and Gurvich C: Development and validation of a
new rating scale for perimenopausal depression-the Meno-D. Transl
Psychiatry. 8:1232018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bromberger JT and Kravitz HM: Mood and
menopause: Findings from the study of women's health across the
nation (SWAN) over 10 years. Obstet Gynecol Clin North Am.
38:609–625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen MH, Su TP, Li CT, Chang WH, Chen TJ
and Bai YM: Symptomatic menopausal transition increases the risk of
new-onset depressive disorder in later life: A nationwide
prospective cohort study in Taiwan. PLoS One. 8:e598992013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bromberger JT, Kravitz HM, Chang Y,
Randolph JF Jr, Avis NE, Gold EB and Matthews KA: Does risk for
anxiety increase during the menopausal transition? Study of women's
health across the nation. Menopause. 20:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hogervorst E, Craig J and O'Donnell E:
Cognition and mental health in menopause: A review. Best Pract Res
Clin Obstet Gynaecol. 81:69–84. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pertesi S, Coughlan G, Puthusseryppady V,
Morris E and Hornberger M: Menopause, cognition and dementia-a
review. Post Reprod Health. 25:200–206. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sochocka M, Karska J, Pszczołowska M,
Ochnik M, Fułek M, Fułek K, Kurpas D, Chojdak-Łukasiewicz J,
Rosner-Tenerowicz A and Leszek J: Cognitive decline in early and
premature menopause. Int J Mol Sci. 24:65662023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Coborn J, de Wit A, Crawford S, Nathan M,
Rahman S, Finkelstein L, Wiley A and Joffe H: Disruption of Sleep
continuity during the perimenopause: Associations with female
reproductive hormone profiles. J Clin Endocrinol Metab.
107:e4144–e4153. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Baker FC, de Zambotti M, Colrain IM and
Bei B: Sleep problems during the menopausal transition: Prevalence,
impact, and management challenges. Nat Sci Sleep. 10:73–95. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhou Q, Wang B, Hua Q, Jin Q, Xie J, Ma J
and Jin F: Investigation of the relationship between hot flashes,
sweating and sleep quality in perimenopausal and postmenopausal
women: The mediating effect of anxiety and depression. BMC Womens
Health. 21:2932021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Aras SG, Grant AD and Konhilas JP:
Clustering of >145,000 symptom logs reveals distinct pre, peri,
and menopausal phenotypes. Sci Rep. 15:6402025. View Article : Google Scholar
|
|
47
|
Cray LA, Woods NF, Herting JR and Mitchell
ES: Symptom clusters during the late reproductive stage through the
early postmenopause: Observations from the seattle midlife women's
health study. Menopause. 19:864–869. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Eberling JL, Wu C, Tong-Turnbeaugh R and
Jagust WJ: Estrogen- and tamoxifen-associated effects on brain
structure and function. Neuroimage. 21:364–371. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bromberger JT, Schott LL, Kravitz HM,
Sowers M, Avis NE, Gold EB, Randolph JF Jr and Matthews KA:
Longitudinal change in reproductive hormones and depressive
symptoms across the menopausal transition: Results from the study
of women's health across the nation (SWAN). Arch Gen Psychiatry.
67:598–607. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Musial N, Ali Z, Grbevski J, Veerakumar A
and Sharma P: Perimenopause and first-onset mood disorders: A
closer look. Focus (Am Psychiatr Publ). 19:330–337. 2021.PubMed/NCBI
|
|
51
|
Turek J and Gąsior Ł: Estrogen
fluctuations during the menopausal transition are a risk factor for
depressive disorders. Pharmacol Rep. 75:32–43. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
He L, Guo W, Qiu J, An X and Lu W: Altered
spontaneous brain activity in women during menopause transition and
its association with cognitive function and serum estradiol level.
Front Endocrinol (Lausanne). 12:6525122021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Meinhard N, Kessing LV and Vinberg M: The
role of estrogen in bipolar disorder, a review. Nord J Psychiatry.
68:81–87. 2014. View Article : Google Scholar
|
|
54
|
Wharton W, Gleason CE, Olson SRMS,
Carlsson CM and Asthana S: Neurobiological underpinnings of the
estrogen-mood relationship. Curr Psychiatry Rev. 8:247–256. 2012.
View Article : Google Scholar
|
|
55
|
Newhouse P and Albert K: Estrogen, stress,
and depression: A neurocognitive model. JAMA Psychiatry.
72:727–729. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Simpkins JW, Yang SH, Sarkar SN and Pearce
V: Estrogen actions on mitochondria-physiological and pathological
implications. Mol Cell Endocrinol. 290:51–59. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Metcalf CA, Duffy KA, Page CE and Novick
AM: Cognitive problems in perimenopause: A review of recent
evidence. Curr Psychiatry Rep. 25:501–511. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Crandall CJ, Larson JC, Ensrud KE, LaCroix
AZ, Guthrie KA, Reed SD, Bhasin S and Diem S: Are serum estrogen
concentrations associated with menopausal symptom bother among
postmenopausal women? Baseline results from two MsFLASH clinical
trials. Maturitas. 162:23–30. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang Z, DiVittorio JR, Joseph AM and
Correa SM: The effects of estrogens on neural circuits that control
temperature. Endocrinology. 162:bqab0872021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Amin Z, Canli T and Epperson CN: Effect of
estrogen-serotonin interactions on mood and cognition. Behav Cogn
Neurosci Rev. 4:43–58. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Rubinow DR, Schmidt PJ and Roca CA:
Estrogen-serotonin interactions: Implications for affective
regulation. Biol Psychiatry. 44:839–850. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Regidor PA: Progesterone in peri-and
postmenopause: A review. Geburtshilfe Frauenheilkd. 74:995–1002.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Memi E, Pavli P, Papagianni M, Vrachnis N
and Mastorakos G: Diagnostic and therapeutic use of oral micronized
progesterone in endocrinology. Rev Endocr Metab Disord. 25:751–772.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Cao G, Meng G, Zhu L, Zhu J, Dong N, Zhou
X, Zhang S and Zhang Y: Susceptibility to chronic immobilization
stress-induced depressive-like behaviour in middle-aged female mice
and accompanying changes in dopamine D1 and GABAA
receptors in related brain regions. Behav Brain Funct. 17:22021.
View Article : Google Scholar
|
|
65
|
Crowley SK, O'Buckley TK, Schiller CE,
Stuebe A, Morrow AL and Girdler SS: Blunted neuroactive steroid and
HPA axis responses to stress are associated with reduced sleep
quality and negative affect in pregnancy: A pilot study.
Psychopharmacology (Berl). 233:1299–1310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Sanna E, Talani G, Busonero F, Pisu MG,
Purdy RH, Serra M and Biggio G: Brain steroidogenesis mediates
ethanol modulation of GABAA receptor activity in rat hippocampus. J
Neurosci. 24:6521–6530. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hantsoo L, Jagodnik KM, Novick AM, Baweja
R, di Scalea TL, Ozerdem A, McGlade EC, Simeonova DI, Dekel S,
Kornfield SL, et al: The role of the hypothalamic-pituitary-adrenal
axis in depression across the female reproductive lifecycle:
current knowledge and future directions. Front Endocrinol
(Lausanne). 14:12952612023. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Oyola MG and Handa RJ:
Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal
axes: Sex differences in regulation of stress responsivity. Stress.
20:476–494. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Soares CN, Almeida OP, Joffe H and Cohen
LS: Efficacy of estradiol for the treatment of depressive disorders
in perimenopausal women: A double-blind, randomized,
placebo-controlled trial. Arch Gen Psychiatry. 58:529–534. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Behrman S and Crockett C: Severe mental
illness and the perimenopause. BJPsych Bull. 48:1–7.
2023.PubMed/NCBI
|
|
71
|
van Staa TP, Cooper C, Barlow D and
Leufkens HGM: Individualizing the risks and benefits of
postmenopausal hormone therapy. Menopause. 15:374–381. 2008.
View Article : Google Scholar
|
|
72
|
Minelli C, Abrams KR, Sutton AJ and Cooper
NJ: Benefits and harms associated with hormone replacement therapy:
Clinical decision analysis. BMJ. 328:3712004. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Rossouw JE, Anderson GL, Prentice RL,
LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA,
Howard BV, Johnson KC, et al: Risks and benefits of estrogen plus
progestin in healthy postmenopausal women: Principal results from
the women's health initiative randomized controlled trial. JAMA.
288:321–333. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Fait T and Vrablik M: Hormone replacement
therapy (HRT) shortages for treating menopause: What can clinicians
do to relieve symptoms and concerns? Sci. 6:462024. View Article : Google Scholar
|
|
75
|
Poluzzi E, Piccinni C, Raschi E, Rampa A,
Recanatini M and De Ponti F: Phytoestrogens in postmenopause: The
state of the art from a chemical, pharmacological and regulatory
perspective. Curr Med Chem. 21:417–436. 2014. View Article : Google Scholar :
|
|
76
|
Stahl SM, Grady MM, Moret C and Briley M:
SNRIs: Their pharmacology, clinical efficacy, and tolerability in
comparison with other classes of antidepressants. CNS Spectr.
10:732–747. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Farach FJ, Pruitt LD, Jun JJ, Jerud AB,
Zoellner LA and Roy-Byrne PP: Pharmacological treatment of anxiety
disorders: Current treatments and future directions. J Anxiety
Disord. 26:833–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Parry BL: Optimal management of
perimenopausal depression. Int J Womens Health. 2:143–151. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wang Y, Wang Y, Yue G and Zhao Y: Energy
metabolism disturbance in migraine: From a mitochondrial point of
view. Front Physiol. 14:11335282023. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Li W, Chen M, Gong Y, Lin F and Sun C:
Effects of dexmedetomidine on oxidative stress, programmed cell
death, liver function, and expression of peripheral immune cells in
patients with primary liver cancer undergoing hepatectomy. Front
Physiol. 14:11597462023. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Chandel NS: Mitochondria. Cold Spring Harb
Perspect Biol. 13:a0405432021. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Martínez-Reyes I and Chandel NS:
Mitochondrial TCA cycle metabolites control physiology and disease.
Nat Commun. 11:1022020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Fields M, Marcuzzi A, Gonelli A, Celeghini
C, Maximova N and Rimondi E: Mitochondria-targeted antioxidants, an
innovative class of antioxidant compounds for neurodegenerative
diseases: Perspectives and limitations. Int J Mol Sci. 24:37392023.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Su B, Wang X, Zheng L, Perry G, Smith MA
and Zhu X: Abnormal mitochondrial dynamics and neurodegenerative
diseases. Biochim Biophys Acta. 1802:135–142. 2010. View Article : Google Scholar
|
|
85
|
Faria-Pereira A and Morais VA: Synapses:
The brain's energy-demanding sites. Int J Mol Sci. 23:36272022.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Dienel GA, Schousboe A, McKenna MC and
Rothman DL: A tribute to Leif Hertz: The historical context of his
pioneering studies of the roles of astrocytes in brain energy
metabolism, neurotransmission, cognitive functions, and
pharmacology identifies important, unresolved topics for future
studies. J Neurochem. 168:461–495. 2024. View Article : Google Scholar
|
|
87
|
Vos M, Lauwers E and Verstreken P:
Synaptic mitochondria in synaptic transmission and organization of
vesicle pools in health and disease. Front Synaptic Neurosci.
2:1392010. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Glancy B and Balaban RS: Role of
mitochondrial Ca2+ in the regulation of cellular energetics.
Biochemistry. 51:2959–2973. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Krols M, van Isterdael G, Asselbergh B,
Kremer A, Lippens S, Timmerman V and Janssens S:
Mitochondria-associated membranes as hubs for neurodegeneration.
Acta Neuropathol. 131:505–523. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Tassone A, Meringolo M, Ponterio G, Bonsi
P, Schirinzi T and Martella G: Mitochondrial bioenergy in
neurodegenerative disease: Huntington and Parkinson. Int J Mol Sci.
24:72212023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Giorgi C, Missiroli S, Patergnani S,
Duszynski J, Wieckowski MR and Pinton P: Mitochondria-associated
membranes: Composition, molecular mechanisms, and
physiopathological implications. Antioxid Redox Signal.
22:995–1019. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Murphy MP: How mitochondria produce
reactive oxygen species. Biochem J. 417:1–13. 2009. View Article : Google Scholar
|
|
93
|
Tönnies E and Trushina E: Oxidative
stress, synaptic dysfunction, and Alzheimer's disease. J Alzheimers
Dis. 57:1105–1121. 2017. View Article : Google Scholar
|
|
94
|
Kim KH and Lee CB: Socialized
mitochondria: Mitonuclear crosstalk in stress. Exp Mol Med.
56:1033–1042. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kowalczyk P, Sulejczak D, Kleczkowska P,
Bukowska-Ośko I, Kucia M, Popiel M, Wietrak E, Kramkowski K,
Wrzosek K and Kaczyńska K: Mitochondrial oxidative stress-a
causative factor and therapeutic target in many diseases. Int J Mol
Sci. 22:133842021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Forceville X, Van Antwerpen P and Preiser
JC: Selenocompounds and sepsis: Redox bypass hypothesis for early
diagnosis and treatment: Part A-early acute phase of sepsis: An
extraordinary redox situation (leukocyte/endothelium interaction
leading to endothelial damage). Antioxid Redox Signal. 35:113–138.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Tu W, Wang H, Li S, Liu Q and Sha H: The
anti-inflammatory and anti-oxidant mechanisms of the keap1/Nrf2/ARE
signaling pathway in chronic diseases. Aging Dis. 10:637–651. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Ferber EC, Peck B, Delpuech O, Bell GP,
East P and Schulze A: FOXO3a regulates reactive oxygen metabolism
by inhibiting mitochondrial gene expression. Cell Death Differ.
19:968–979. 2012. View Article : Google Scholar :
|
|
99
|
Liu L, Li Y, Wang J, Zhang D, Wu H, Li W,
Wei H, Ta N, Fan Y, Liu Y, et al: Mitophagy receptor FUNDC1 is
regulated by PGC-1α/NRF1 to fine tune mitochondrial homeostasis.
EMBO Rep. 22:e506292021. View Article : Google Scholar
|
|
100
|
Tirichen H, Yaigoub H, Xu W, Wu C, Li R
and Li Y: Mitochondrial reactive oxygen species and their
contribution in chronic kidney disease progression through
oxidative stress. Front Physiol. 12:6278372021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Huang E, Qu D, Huang T, Rizzi N, Boonying
W, Krolak D, Ciana P, Woulfe J, Klein C, Slack RS, et al:
PINK1-mediated phosphorylation of LETM1 regulates mitochondrial
calcium transport and protects neurons against mitochondrial
stress. Nat Commun. 8:13992017. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Giménez-Palomo A, Dodd S, Anmella G,
Carvalho AF, Scaini G, Quevedo J, Pacchiarotti I, Vieta E and Berk
M: The role of mitochondria in mood disorders: From physiology to
pathophysiology and to treatment. Front Psychiatry. 12:5468012021.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Fakhri S, Abdian S, Zarneshan SN, Akkol
EK, Farzaei MH and Sobarzo-Sánchez E: Targeting mitochondria by
plant secondary metabolites: A promising strategy in combating
Parkinson's disease. Int J Mol Sci. 22:125702021. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Vogler M, Braun Y, Smith VM, Westhoff MA,
Pereira RS, Pieper NM, Anders M, Callens M, Vervliet T, Abbas M, et
al: The BCL2 family: From apoptosis mechanisms to new advances in
targeted therapy. Signal Transduct Target Ther. 10:912025.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
de Oliveira MR, Nabavi SF, Habtemariam S,
Erdogan Orhan I, Daglia M and Nabavi SM: The effects of baicalein
and baicalin on mitochondrial function and dynamics: A review.
Pharmacol Res. 100:296–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Shen X, Sun P, Zhang H and Yang H:
Mitochondrial quality control in the brain: The physiological and
pathological roles. Front Neurosci. 16:10751412022. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Gaignard P, Liere P, Thérond P, Schumacher
M, Slama A and Guennoun R: Role of sex hormones on brain
mitochondrial function, with special reference to aging and
neurodegenerative diseases. Front Aging Neurosci. 9:4062017.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Kemper MF, Stirone C, Krause DN, Duckles
SP and Procaccio V: Genomic and non-genomic regulation of PGC1
isoforms by estrogen to increase cerebral vascular mitochondrial
biogenesis and reactive oxygen species protection. Eur J Pharmacol.
723:322–329. 2014. View Article : Google Scholar :
|
|
109
|
Guajardo-Correa E, Silva-Agüero JF, Calle
X, Chiong M, Henríquez M, García-Rivas G, Latorre M and Parra V:
Estrogen signaling as a bridge between the nucleus and mitochondria
in cardiovascular diseases. Front Cell Dev Biol. 10:9683732022.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Velarde MC: Mitochondrial and sex steroid
hormone crosstalk during aging. Longev Healthspan. 3:22014.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Klinge CM: Estrogenic control of
mitochondrial function and biogenesis. J Cell Biochem.
105:1342–1351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Rettberg JR, Yao J and Brinton RD:
Estrogen: A master regulator of bioenergetic systems in the brain
and body. Front Neuroendocrinol. 35:8–30. 2014. View Article : Google Scholar :
|
|
113
|
Kobayashi A, Azuma K, Ikeda K and Inoue S:
Mechanisms underlying the regulation of mitochondrial respiratory
chain complexes by nuclear steroid receptors. Int J Mol Sci.
21:66832020. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Stirone C, Duckles SP, Krause DN and
Procaccio V: Estrogen increases mitochondrial efficiency and
reduces oxidative stress in cerebral blood vessels. Mol Pharmacol.
68:959–965. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Salnikova D, Orekhova V, Grechko A,
Starodubova A, Bezsonov E, Popkova T and Orekhov A: Mitochondrial
dysfunction in vascular wall cells and its role in atherosclerosis.
Int J Mol Sci. 22:89902021. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Kim SO, Albrecht ED and Pepe GJ: Estrogen
promotes fetal skeletal muscle mitochondrial distribution and ATP
synthase activity important for insulin sensitivity in offspring.
Endocrine. 85:417–427. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Yin L, Luo M, Wang R, Ye J and Wang X:
Mitochondria in sex hormone-induced disorder of energy metabolism
in males and females. Front Endocrinol (Lausanne). 12:7494512021.
View Article : Google Scholar
|
|
118
|
Miao C, Zhao Y, Chen Y, Wang R, Ren N, Liu
Q, Dou X and Zhang Q: He's Yangchao recipe improves premature
ovarian insufficiency by regulating mitochondrial biogenesis of
granulose cells via ERβ/PGC1α/TFAM pathway. Zhejiang Da Xue Xue Bao
Yi Xue Ban. 53:358–367. 2024.In English, Chinese. PubMed/NCBI
|
|
119
|
Mosconi L, Berti V, Dyke J, Schelbaum E,
Jett S, Loughlin L, Jang G, Rahman A, Hristov H, Pahlajani S, et
al: Menopause impacts human brain structure, connectivity, energy
metabolism, and amyloid-beta deposition. Sci Rep. 11:108672021.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Mosconi L, Berti V, Quinn C, McHugh P,
Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S,
Isaacson RS, et al: Perimenopause and emergence of an Alzheimer's
bioenergetic phenotype in brain and periphery. PLoS One.
12:e01859262017. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Lejri I, Grimm A and Eckert A:
Mitochondria, estrogen and female brain aging. Front Aging
Neurosci. 10:1242018. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Zhao W, Hou Y, Song X, Wang L, Zhang F,
Zhang H, Yu H and Zhou Y: Estrogen deficiency induces mitochondrial
damage prior to emergence of cognitive deficits in a postmenopausal
mouse model. Front Aging Neurosci. 13:7138192021. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Duan P, Liu Y, Lin X, Ren J, He J, Liu X
and Xie J: Extracellular matrix stiffness induces mitochondrial
morphological heterogeneity via AMPK activation. Sichuan Da Xue Xue
Bao Yi Xue Ban. 55:47–52. 2024.In Chinese. PubMed/NCBI
|
|
124
|
Tsuchiya T, Takei A, Tsujikado K and
Inukai T: Effects of androgens and estrogens on sirtuin 1 gene
expression in human aortic endothelial cells. Saudi Med J.
41:361–368. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Chen JQ, Brown TR and Russo J: Regulation
of energy metabolism pathways by estrogens and estrogenic chemicals
and potential implications in obesity associated with increased
exposure to endocrine disruptors. Biochim Biophys Acta.
1793:1128–1143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Plovanich M, Bogorad RL, Sancak Y, Kamer
KJ, Strittmatter L, Li AA, Girgis HS, Kuchimanchi S, De Groot J,
Speciner L, et al: MICU2, a paralog of MICU1, resides within the
mitochondrial uniporter complex to regulate calcium handling. PLoS
One. 8:e557852013. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Hunter JC, Machikas AM and Korzick DH:
Age-dependent reductions in mitochondrial respiration are
exacerbated by calcium in the female rat heart. Gend Med.
9:197–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Sayehmiri F, Motamedi F, Batool Z, Naderi
N, Shaerzadeh F, Zoghi A, Rezaei O, Khodagholi F and Pourbadie HG:
Mitochondrial plasticity and synaptic plasticity crosstalk; in
health and Alzheimer's disease. CNS Neurosci Ther. 30:e148972024.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Alemany M: Estrogens and the regulation of
glucose metabolism. World J Diabetes. 12:1622–1654. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Arjmand S, Ilaghi M, Sisakht AK, Guldager
MB, Wegener G, Landau AM and Gjedde A: Regulation of mitochondrial
dysfunction by estrogens and estrogen receptors in Alzheimer's
disease: A focused review. Basic Clin Pharmacol Toxicol.
135:115–132. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng
Y, Zhang C, Liu D, Zheng M and Gao J: Mitochondrial dysfunction:
Mechanisms and advances in therapy. Signal Transduct Target Ther.
9:1242024. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Bencker C, Gschwandtner L, Nayman S,
Grikšienė R, Nguyen B, Nater UM, Guennoun R, Sundström-Poromaa I,
Pletzer B, Bixo M and Comasco E: Progestagens and progesterone
receptor modulation: Effects on the brain, mood, stress, and
cognition in females. Front Neuroendocrinol. 76:1011602025.
View Article : Google Scholar
|
|
133
|
Lee JHA, Chen Q and Zhuo M: Synaptic
plasticity in the pain-related cingulate and insular cortex.
Biomedicines. 10:27452022. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Genazzani AR, Bernardi F, Pluchino N,
Begliuomini S, Lenzi E, Casarosa E and Luisi M: Endocrinology of
menopausal transition and its brain implications. CNS Spectr.
10:449–457. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Jiang M, Wang L and Sheng H: Mitochondria
in depression: The dysfunction of mitochondrial energy metabolism
and quality control systems. CNS Neurosci Ther. 30:e145762024.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Chen JQ, Cammarata PR, Baines CP and Yager
JD: Regulation of mitochondrial respiratory chain biogenesis by
estrogens/estrogen receptors and physiological, pathological and
pharmacological implications. Biochim Biophys Acta. 1793:1540–1570.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Wong-Riley MTT: Bigenomic regulation of
cytochrome c oxidase in neurons and the tight coupling between
neuronal activity and energy metabolism. Adv Exp Med Biol.
748:283–304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Mosconi L, Jett S, Nerattini M, Andy C,
Yepez CB, Zarate C, Carlton C, Kodancha V, Schelbaum E, Williams S,
et al: In vivo brain estrogen receptor expression by neuroendocrine
aging and relationships with gray matter volume, bio-energetics,
and clinical symptomatology. Res Sq. [Preprint] rs.3.rs-2573335.
2023.
|
|
139
|
Tung C, Varzideh F, Farroni E, Mone P,
Kansakar U, Jankauskas SS and Santulli G: Elamipretide: A review of
its structure, mechanism of action, and therapeutic potential. Int
J Mol Sci. 26:9442025. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Liang L, Chen J, Xiao L, Wang Q and Wang
G: Mitochondrial modulators in the treatment of bipolar depression:
A systematic review and meta-analysis. Transl Psychiatry. 12:42022.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Tang L, Tang R, Zheng J, Zhao P, Zhu R,
Tang Y, Zhang X, Gong X and Wang F: Dissecting biological
heterogeneity in major depressive disorder based on neuroimaging
subtypes with multi-omics data. Transl Psychiatry. 15:722025.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Sun X, Sun J, Lu X, Dong Q, Zhang L, Wang
W, Liu J, Ma Q, Wang X, Wei D, et al: Mapping neurophysiological
subtypes of major depressive disorder using normative models of the
functional connectome. Biol Psychiatry. 94:936–947. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Bousman CA, Stevenson JM, Ramsey LB,
Sangkuhl K, Hicks JK, Strawn JR, Singh AB, Ruaño G, Mueller DJ,
Tsermpini EE, et al: Clinical pharmacogenetics implementation
consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4,
and HTR2A genotypes and serotonin reuptake inhibitor
antidepressants. Clin Pharmacol Ther. 114:51–68. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Cooper CM, Chin Fatt CR, Jha M, Fonzo GA,
Grannemann BD, Carmody T, Ali A, Aslan S, Almeida JRC, Deckersbach
T, et al: Cerebral blood perfusion predicts response to sertraline
versus placebo for major depressive disorder in the EMBARC trial.
EClinicalMedicine. 10:32–41. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Uher R, Tansey KE, Dew T, Maier W, Mors O,
Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Farmer A and
McGuffin P: An inflammatory biomarker as a differential predictor
of outcome of depression treatment with escitalopram and
nortriptyline. Am J Psychiatry. 171:1278–1286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Yan LJ: Positive oxidative stress in aging
and aging-related disease tolerance. Redox Biol. 2:165–169. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Parnan Emamverdikhan A, Golmakani N,
Tabassi SA, Hassanzadeh M, Sharifi N and Shakeri MT: A survey of
the therapeutic effects of vitamin E suppositories on vaginal
atrophy in postmenopausal women. Iran J Nurs Midwifery Res.
21:475–481. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Lin G, Li X, Jin Yie SL and Xu L: Clinical
evidence of coenzyme Q10 pretreatment for women with diminished
ovarian reserve undergoing IVF/ICSI: A systematic review and
meta-analysis. Ann Med. 56:23894692024. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Fang YQ, Ding H, Li T, Zhao XJ, Luo D, Liu
Y and Li Y: N-acetylcysteine supplementation improves
endocrine-metabolism profiles and ovulation induction efficacy in
polycystic ovary syndrome. J Ovarian Res. 17:2052024. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Liang G, Kow ASF, Yusof R, Tham CL, Ho YC
and Lee MT: Menopause-associated depression: Impact of oxidative
stress and neuroinflammation on the central nervous system-a
review. Biomedicines. 12:1842024. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Wagner AE, Ernst IMA, Birringer M, Sancak
O, Barella L and Rimbach G: A combination of lipoic acid plus
coenzyme Q10 induces PGC1α, a master switch of energy metabolism,
improves stress response, and increases cellular glutathione levels
in cultured C2C12 skeletal muscle cells. Oxid Med Cell Longev.
2012:8359702012. View Article : Google Scholar
|
|
152
|
Shon J, Seong Y, Choi Y and Kim Y, Cho MS,
Ha E, Kwon O and Kim Y, Park YJ and Kim Y: Meal-based intervention
on health promotion in middle-aged women: A pilot study. Nutrients.
15:21082023. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Shavaisi F, Heydarpour S, Jalilian N,
Jalali A and Rezaei M: The effects of positive psychology and
physical activity on depression, anxiety, and stress among students
with premenstrual syndrome: A single-blind, randomized controlled
trial. BMC Womens Health. 24:4992024. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Xu W, Gao W, Guo Y, Xue F, Di L, Fang S,
Fan L, He Y, Zhou Y, Xie X and Pang X: Targeting mitophagy for
depression amelioration: A novel therapeutic strategy. Front
Neurosci. 17:12352412023. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Buck AC, Maarman GJ, Dube A and Bardien S:
Mitochondria targeted nanoparticles for the treatment of
mitochondrial dysfunction-associated brain disorders. Front Bioeng
Biotechnol. 13:15637012025. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Ge M, Ding Y, Hu T, Chen Y, Shahin V, Li
B, Huang T, Qian Y, Zhou Z, Tao Y, et al: Nanomedicine-enabled
next-generation therapeutics for spinal cord injury. Mater Today.
86:522–547. 2025. View Article : Google Scholar
|
|
157
|
Buchke S, Sharma M, Bora A, Relekar M,
Bhanu P and Kumar J: Mitochondria-targeted, nanoparticle-based
drug-delivery systems: Therapeutics for mitochondrial disorders.
Life (Basel). 12:6572022.PubMed/NCBI
|
|
158
|
Li M, Yu Y, Xue K, Li J, Son G, Wang J,
Qian W, Wang S, Zheng J, Yang C and Ge J: Genistein mitigates
senescence of bone marrow mesenchymal stem cells via ERRα-mediated
mitochondrial biogenesis and mitophagy in ovariectomized rats.
Redox Biol. 61:1026492023. View Article : Google Scholar
|
